Oneness USA Biotech Co Limited

Oneness Biotech was established in 2008 and listed on the Taiwan TPEx market in September 2011. The company is dedicated to the research and development of First-in-Class and Best-in-Class global innovative drugs and medical devices, focusing on the treatment of wounds, chronic skin diseases, immunological and metabolic disorders, as well as the development of novel small nucleic acid new drugs.